However, another study has already reported that selumetinib can cause apoptosis in some human tumour xenografts, but not in others, which was suggested to be due to differences in ERK1/2 substrate expression or differential cell signalling networks [35], and hence the result with WX-554 is not entirely unexpected. Here, MAPK3 is linked to neoplasm.